321 results
Page 4 of 17
8-K
EX-99.1
c5a18o
14 May 21
Edesa Biotech Reports Fiscal 2nd Quarter 2021 Results
8:02am
8-K
EX-10.1
n9mse 1wi6uyoye9
22 Mar 21
Entry into a Material Definitive Agreement
8:00am
424B5
sd1yv5x4pz3yl8c6apxp
26 Feb 21
Prospectus supplement for primary offering
4:13pm
8-K/A
EX-99.2
5d68ejz
26 Feb 21
Edesa Biotech Announces $3.5 Million Bought Deal Offering of Common Shares
4:10pm
8-K/A
EX-1.1
x4rojvqtwhdilzg3nz3j
26 Feb 21
Edesa Biotech Announces $3.5 Million Bought Deal Offering of Common Shares
4:10pm
8-K/A
EX-99.1
m0bjmrsih
26 Feb 21
Edesa Biotech Announces $3.5 Million Bought Deal Offering of Common Shares
4:10pm
8-K
EX-99.2
zqee f84zfuvh
26 Feb 21
Edesa Biotech Announces $3.5 Million Bought Deal Offering of Common Shares
6:30am
8-K
EX-99.1
jmp9msouv4hp1xbh4z
26 Feb 21
Edesa Biotech Announces $3.5 Million Bought Deal Offering of Common Shares
6:30am
FWP
9x6gh 9pu9
26 Feb 21
Free writing prospectus
6:05am
FWP
ax1xxrm
25 Feb 21
Free writing prospectus
5:25pm
424B5
cmr xs5nvg
25 Feb 21
Prospectus supplement for primary offering
4:48pm
8-K
EX-99.1
g5rzt14riy
16 Feb 21
Edesa Biotech Reports Fiscal First Quarter 2021 Results
7:30am
8-K
EX-99.1
eeqh9yy3yrluj8
3 Feb 21
Edesa Biotech Receives C$14 million for COVID-19 Study
8:00am